Analytical and Bioanalytical Sciences
- Pharmaceutical Analysis: Method Transfer & Lifecycle
- Method development & validation (ICH Q2/Q14), stability-indicating methods
- Large-molecule analytics: CE/SDS-PAGE, LC-MS for intact/peptide mapping
- CQAs for biologics, glycan & charge variant analysis
- Potency/bioassays, immunogenicity & ADA/NAb analytics
- Next-gen characterization for ATMPs & RNA (caps, integrity, impurities)
- Real-time release testing (RTRT) & process analytical technology (PAT)
- Multi-Attribute Methods (MAM) & Host Cell Protein (HCP) Analytics
- Cell-Based Potency Assays: Lifecycle & Validation
- Viral Safety & Adventitious Agent Testing for ATMPs
Reliable analytical data form the backbone of pharmaceutical quality, safety, and regulatory compliance. Analytical and Bioanalytical Sciences focuses on the principles, technologies, and innovations that enable accurate characterization of drug substances, formulations, and biological samples. This session explores the full analytical lifecycle—from method development and validation to real-time release and advanced structural analysis. It serves as a bridge between discovery, CMC, and regulatory expectations, ensuring every measurement contributes to the integrity of drug development.
Participants will gain insights into cutting-edge techniques used to characterize both small molecules and biologics. The session discusses LC–MS, CE, and NMR for structure elucidation; chromatographic and spectroscopic tools for impurity profiling; and immunoassays and ligand-binding methods for bioanalysis. Modern discussions will emphasize complex molecule analysis such as glycan mapping, charge variants, and higher-order structure assessment. The growing impact of automation and multi-attribute methods (MAM) will also be addressed, showing how digital analytics accelerate data interpretation and regulatory readiness.
Bioanalytical scientists will find dedicated content on assay validation, immunogenicity testing, and cell-based potency methods essential for biologics and biosimilars. Participants will also explore how real-time release testing (RTRT) and process analytical technology (PAT) link analytics directly with manufacturing. By aligning data integrity principles with advanced instrumentation, the session builds a foundation for efficient, reproducible, and compliant analytical operations.
With global expectations evolving, this track addresses harmonized guidelines like ICH Q2(R2)/Q14 for analytical procedure development and lifecycle management. Case studies illustrate how laboratories implement analytical control strategies within quality-by-design (QbD) frameworks. Professionals searching for a Pharmaceutical Conference will gain exposure to the latest regulatory updates, assay automation trends, and digital validation tools. Critical areas such as analytical method validation are explored in depth to help scientists build confidence in data quality, reliability, and audit readiness.
Whether you work in discovery support, CMC development, or QC laboratories, this session delivers the scientific and operational insights needed to ensure every measurement counts—accurate, compliant, and defensible.
Ready to Share Your Research?
Submit Your Abstract Here →Present your research under Analytical and Bioanalytical Sciences
Key Analytical Disciplines and Applications
Method Development & Validation
- Building stability-indicating assays following ICH Q2(R2)/Q14 frameworks.
- Ensuring linearity, precision, and accuracy for robust analytical results.
Structural and Impurity Characterization
- LC–MS, CE, and NMR for structure, impurities, and degradation profiling.
- Advanced detection of nitrosamines, extractables, and leachables.
Large Molecule Analytics
- Characterization of glycoforms, charge variants, and aggregation profiles.
- Use of peptide mapping and intact mass analysis for biologic confirmation.
Bioassays and Immunogenicity
- Potency testing and cell-based assay validation ensuring product consistency.
- Detection of anti-drug antibodies (ADA/NAb) in preclinical and clinical studies.
Process Analytical Technology (PAT)
- Inline monitoring linking quality attributes to process control.
- RTRT applications accelerating product release and reducing testing delays.
Data Integrity and Digitalization
- Implementing ALCOA+ principles and secure, compliant data systems.
- Automation and electronic workflows improving traceability and efficiency.
Analytical Excellence and Impact
Comprehensive Characterization
Delivers accurate, high-resolution data to define molecular identity.
Regulatory Alignment
Ensures analytical lifecycle compliance with ICH and FDA expectations.
Efficiency through Innovation
Adopts automation, MAM, and digital validation for speed and accuracy.
Quality by Design Integration
Links analytical performance with product and process understanding.
Cross-Disciplinary Relevance
Supports discovery, formulation, and manufacturing with unified analytics.
Bioanalytical Advancement
Drives innovation in potency, immunogenicity, and PK assay development.
Data Integrity Culture
Promotes reproducibility, transparency, and audit readiness.
Future-Ready Labs
Prepares teams for digital transformation in analytical science.
Related Sessions You May Like
Join the Global Pharmaceutical Sciences Community
Connect with top researchers, industry experts, and innovators worldwide. Share your work and explore the latest advancements in drug discovery, translational research, and next-generation therapeutics.